Journals / Erciyes Medical Journal / 2021 / Cilt: 43 - Sayı: 3

Somatosensory Amplification, Health Anxiety andPain Catastrophizing in Individuals with ChronicMusculoskeletal System Pain

Pages
237–243
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was also found thatfor SSAS and PCS, the patient group had higher scores than the controls (p=0.008 and p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The present study aimed to evaluate the somatosensory amplification, pain catastrophizing levels, and health anx iety of the patients with musculoskeletal system pain through comparing them both with control group and with themselves.
📊
Key Findings & Data:Results: The patient group had 120 patients (45 – FMS, 27 – OA, 29 – LDH, and 19 – CDH diagnoses) while the controlhad 70 individuals.
💡
Conclusion & Impact:It was also found thatfor SSAS and PCS, the patient group had higher scores than the controls (p=0.008 and p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The present study aimed to evaluate the somatosensory amplification, pain catastrophizing levels, and health anx iety of the patients with musculoskeletal system pain through comparing them both with control group and with themselves. Materials and Methods: Of all patients who applied to the physical therapy and rehabilitation outpatient clinic with acomplaint of musculoskeletal pain and who met the criteria for inclusion. The patients diagnosed with fibromyalgia syn drome (FMS) and osteoarthritis (OA) based on American College of Rheumatology criteria and the patients diagnosed withcervical disc hernia (CDH) and lumbar disc hernia (LDH) based on anamnesis, physical examination, and imaging methodswere included in the study. All participants were subjected to demographic data form, the pain catastrophizing scale (PCS),somatosensory amplification scale (SSAS), hospital anxiety-depression scale (HADS), and health anxiety inventory (HAI). Results: The patient group had 120 patients (45 – FMS, 27 – OA, 29 – LDH, and 19 – CDH diagnoses) while the controlhad 70 individuals. There were no differences between the study groups for demographic data except for working status andeconomic level. It was determined that there were no differences between the patient and control groups for any subscales ofHADS. For HAI only, the “negative consequences” subscale was lower in the patient group (p=0.012). It was also found thatfor SSAS and PCS, the patient group had higher scores than the controls (p=0.008 and p

🔖

Cite This Article

OKAN, S., ÖZSOY, F. (2022). Somatosensory Amplification, Health Anxiety andPain Catastrophizing in Individuals with ChronicMusculoskeletal System Pain. Erciyes Medical Journal, Cilt: 43 - Sayı: 3, 237–243. https://ajindex.com/articles/502191

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Reiser SJ, McMillan KA, Wright KD, Asmundson GJ. Adverse childhood experiences and health anxiety in adulthood. Child Abuse Negl 2014; 38(3): 407–13
  2. Hofmann SG, Asmundson GJ, Beck AT. The science of cognitive therapy. Behav Ther 2013; 44(2): 199–212
  3. Aydemir Ö, Kirpinar I, Sati T, Uykur B, Cengisiz C. Reliability and validity study of Turkish for health anxiety inventory. Noro Psikiyatr Ars 2013; 50(4): 325–31
  4. Taycan O, Özdemir A, Taycan SE. Alexithymia and somatization in depressed patients: The role of the type of somatic symptom attribution. Noro Psikiyatr Ars 2017; 54(2): 99–104
  5. Anuk D, Bahadır G. The association of experience of violence and somatization, depression, and alexithymia: A sample of women with medically unexplained symptoms in Turkey. Arch Womens Ment Health 2018; 21(1): 93–103
  6. İnanıcı F. Fibromyalgia Syndrome. 2nd ed. Ankara: Güneş Bookstores Press; 2011. p. 2365–77
  7. López-Ruiz M, Losilla JM, Monfort J, Portell M, Gutiérrez T, Poca V, et al. Central sensitization in knee osteoarthritis and fibromyalgia: Beyond depression and anxiety. PLoS One 2019; 14(12): e0225836
  8. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American college of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010; 62(5): 600–10
  9. Tuncer T, Çay HF, Kaçar C, Altan L, Atik OŞ, Aydın AT, et al. Evidence-based recommendations for the management of knee osteoarthritis: A consensus report of the Turkish league against rheumatism. Turk J Rheumatol 2012; 27(1): 1–17
  10. Aguglia A, Salvi V, Maina G, Rossetto I, Aguglia E. Fibromyalgia syndrome and depressive symptoms: Comorbidity and clinical correlates. J Affect Disord 2011; 128(3): 262–6
  11. Darnall BD, Sturgeon JA, Cook KF, Taub CJ, Roy A, Burns JW, et al. Development and validation of a daily pain catastrophizing scale. J Pain 2017; 18(9): 1139–49
  12. Malfliet A, van Oosterwijck J, Meeus M, Cagnie B, Danneels L, Dolphens M, et al. Kinesiophobia and maladaptive coping strategies prevent improvements in pain catastrophizing following pain neuroscience education in fibromyalgia/chronic fatigue syndrome: An explorative study. Physiother Theory Pract 2017; 33(8): 653–60
  13. Zigmond AS, Snaith PR. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67(6): 361–70
  14. Salkovskis PM, Rimes KA, Warwick HM, Clark DM. The health anxiety inventory: Development and